Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: A phase II study No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results